Alnylam price target lowered to $161 from $171 at Wells Fargo

Wells Fargo lowered the firm’s price target on Alnylam to $161 from $171 and keeps an Equal Weight rating on the shares. The firm believes the risk/reward remains balanced and awaits a cleaner entry point post-HELIOS-B.